|
NMDA receptor antagonist
Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs.
calcium channel blocker
One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.
|
|
|
geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
|
|
|
rac-1-(4-chlorophenyl)-2-[4-(4-fluorobenzyl)piperidin-1-yl]ethanol
|
|
(±)-α-(p-chlorophenyl)-4-(p-fluorobenzyl)-1-piperidineethanol
|
ChemIDplus
|
|
(±)-eliprodil
|
ChEBI
|
|
(RS)-eliprodil
|
ChEBI
|
|
rac-1-(4-chlorophenyl)-2-{4-[(4-fluorophenyl)methyl]piperidin-1-yl}ethan-1-ol
|
IUPAC
|
|
racemic eliprodil
|
ChEBI
|
|
SL 820715
|
ChEBI
|
|
SL-82,0715
|
ChEBI
|
|
SL-82.0715
|
ChEBI
|
|
SL-820715
|
ChEBI
|
|
SL820715
|
ChEBI
|
